Back to top

Top Ranked Momentum Stocks to Buy for May 18th

Read MoreHide Full Article

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 18th:

AcelRxPharmaceuticals, Inc. (ACRX - Free Report) : This operator of a specialty pharmaceutical companyhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 13.3% over the last 60 days.

AcelRx Pharmaceuticals, Inc. Price and Consensus

AcelRx’s shares gained 25% over the last one month more than S&P 500’s gain of 0.4%. The company possesses a Momentum Score of A.

AcelRx Pharmaceuticals, Inc. Price

Acer Therapeutics Inc. (ACER - Free Report) : This developer of therapies for ultra-rare diseaseshas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 17.2% over the last 60 days.

Opexa Therapeutics, Inc. Price and Consensus

Acer Therapeutics’ shares gained 4% over the last one month. The company possesses a Momentum Score of A.

Opexa Therapeutics, Inc. Price

Arbor Realty Trust, Inc. (ABR - Free Report) : This provider of financial management services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 14.4% over the last 60 days.

Arbor Realty Trust Price and Consensus

Arbor Realty’s shares gained 6.6% over the last one month. The company possesses a Momentum Score of A.

Arbor Realty Trust Price

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


AcelRx Pharmaceuticals, Inc. (ACRX) - free report >>

Opexa Therapeutics, Inc. (ACER) - free report >>

Arbor Realty Trust (ABR) - free report >>

More from Zacks Zacks #1 Rank Additions

You May Like